Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice

Hepatology

Volumn 56, Issue 2, 2012, Pages 585-593

  Delima, Roheeth D ^a,b   Chua, Anita C G ^a,b   Tirnitz Parker, Janina E E ^a,b,c   Gan, Eng K ^a,d   Croft, Kevin D ^a   Graham, Ross M ^a,b,c   Olynyk, John K ^a,b,d,e   Trinder, Debbie ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

^e CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BONE MORPHOGENETIC PROTEIN 6; CD45 ANTIGEN; CD71 ANTIGEN; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; HEMOCHROMATOSIS PROTEIN; HEPCIDIN; INHIBITOR OF DIFFERENTIATION 1; IRON; ISOPROSTANE; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE PROTEIN; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOFLUORESCENCE; IRON BLOOD LEVEL; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER LEVEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ALANINE TRANSAMINASE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MORPHOGENETIC PROTEIN 6; COLLAGEN; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INHIBITOR OF DIFFERENTIATION PROTEIN 1; IRON; IRON OVERLOAD; LIVER; LIVER DISEASES; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; PHENOTYPE; RECEPTORS, TRANSFERRIN;

EID: 84864376907     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25689     Document Type: Article

References (41)

1. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408.
2. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-724.
3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
4. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008; 358: 221-230.
5. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003; 33: 21-22.
6. Girelli D, Bozzini C, Roetto A, Alberti F, Daraio F, Colombari R, et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 2002; 122: 1295-1302.
7. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108: 619-623.
8. Olynyk JK, Trinder D, Ramm GA, Britton RS, Bacon BR. Hereditary hemochromatosis in the post-HFE era. HEPATOLOGY 2008; 48: 991-1001.
9. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron, and response to phlebotomy. J Hepatol 1997; 26: 584-592.
10. Adams PC. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? Am J Gastroenterol 2001; 96: 567-569.
11. Brown KE, Kinter MT, Oberley TD, Freeman ML, Frierson HF, Ridnour LA, et al. Enhanced gamma-glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload. Free Radic Biol Med 1998; 24: 545-555.
12. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996; 88: 3608-3614.
13. Matayatsuk C, Lee CY, Kalpravidh RW, Sirankapracha P, Wilairat P, Fucharoen S, et al. Elevated F2-isoprostanes in thalassemic patients. Free Radic Biol Med 2007; 43: 1649-1655.
14. El Ghissassi F, Barbin A, Nair J, Bartsch H. Formation of 1, N6-ethenoadenine and 3, N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem Res Toxicol 1995; 8: 278-283.
15. Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003; 125: 1733-1741.
16. 32P-postlabeling. Carcinogenesis 1995; 16: 613-617.
17. Pantopoulos K. Function of the hemochromatosis protein HFE: lessons from animal models. World J Gastroenterol 2008; 14: 6893-6901.
18. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 1998; 95: 2492-2497.
19. Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A 2002; 99: 10653-10658.
20. Tan TC, Crawford DH, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, et al. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Am J Physiol Gastrointest Liver Physiol 2011; 301: G865-G876.
21. Chua AC, Delima RD, Morgan EH, Herbison CE, Tirnitz-Parker JE, Graham RM, et al. Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis. J Hepatol 2010; 52: 425-431.
22. Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang RH, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008; 112: 1503-1509.
23. Corradini E, Rozier M, Meynard D, Odhiambo A, Lin HY, Feng Q, et al. Iron regulation of hepcidin despite attenuated Smad1, 5, 8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 2011; 141: 1907-1914.
24. Drake SF, Morgan EH, Herbison CE, Delima R, Graham RM, Chua AC, et al. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 2007; 292: G323-G328.
25. Kaldor I. Studies on intermediary iron metabolism. V. The measurement of non-haemoglobin tissue iron. Aust J Exp Biol Med Sci 1954; 32: 795-799.
26. Tirnitz-Parker JE, Viebahn CS, Jakubowski A, Klopcic BR, Olynyk JK, Yeoh GC, et al. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. HEPATOLOGY 2010; 52: 291-302.
27. 2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999; 268: 117-125.
28. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. HEPATOLOGY 2009; 50: 1992-2000.
29. McLachlan S, Lee SM, Steele TM, Hawthorne PL, Zapala MA, Eskin E, et al. In silico QTL mapping of basal liver iron levels in inbred mouse strains. Physiol Genomics 2011; 43: 136-147.
30. Britton RS, Ramm GA, Olynyk J, Singh R, O'Neill R, Bacon BR. Pathophysiology of iron toxicity. Adv Exp Med Biol 1994; 356: 239-253.
31. Pietrangelo A, Rocchi E, Schiaffonati L, Ventura E, Cairo G. Liver gene expression during chronic dietary iron overload in rats. HEPATOLOGY 1990; 11: 798-804.
32. Lakshmi Devi S, Anuradha CV. Mitochondrial damage, cytotoxicity, and apoptosis in iron-potentiated alcoholic liver fibrosis: amelioration by taurine. Amino Acids 2010; 38: 869-879.
33. Mackinnon M, Clayton C, Plummer J, Ahern M, Cmielewski P, Ilsley A, et al. Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model. HEPATOLOGY 1995; 21: 1083-1088.
34. Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 2000; 23: 185-192.
35. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130: 953-962.
36. Lin E, Adams PC. Biochemical liver profile in hemochromatosis. A survey of 100 patients. J Clin Gastroenterol 1991; 13: 316-320.
37. Jouihan HA, Cobine PA, Cooksey RC, Hoagland EA, Boudina S, Abel ED, et al. Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med 2008; 14: 98-108.
38. Brunt EM. Pathology of hepatic iron overload. Semin Liver Dis 2005; 25: 392-401.
39. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102: 2050-2059.
40. Stal P, Broome U, Scheynius A, Befrits R, Hultcrantz R. Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis. HEPATOLOGY 1995; 21: 1308-1316.
41. Bridle KR, Crawford DH, Fletcher LM, Smith JL, Powell LW, Ramm GA. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. J Hepatol 2003; 38: 426-433.